首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   676篇
  免费   2篇
  国内免费   4篇
安全科学   9篇
环保管理   4篇
综合类   651篇
基础理论   8篇
污染及防治   3篇
评价与监测   2篇
社会与环境   3篇
灾害及防治   2篇
  2021年   6篇
  2020年   1篇
  2018年   2篇
  2017年   3篇
  2016年   2篇
  2013年   4篇
  2012年   5篇
  2011年   34篇
  2010年   35篇
  2009年   34篇
  2008年   28篇
  2007年   38篇
  2006年   40篇
  2005年   55篇
  2004年   44篇
  2003年   43篇
  2002年   59篇
  2001年   28篇
  2000年   1篇
  1999年   2篇
  1996年   1篇
  1995年   27篇
  1994年   44篇
  1993年   22篇
  1992年   14篇
  1991年   25篇
  1990年   12篇
  1989年   12篇
  1988年   15篇
  1987年   11篇
  1986年   4篇
  1985年   11篇
  1984年   11篇
  1983年   3篇
  1982年   2篇
  1981年   4篇
排序方式: 共有682条查询结果,搜索用时 359 毫秒
211.
212.
213.
214.
215.
A mother who had given birth to a child with Schwartz–Jampel syndrome (SJS) with neonatal manifestations (myotonia, congenital contractures, bowing of femora and tibiae) underwent ultrasonic fetal examination during the 17th and 19th week of her second pregnancy. Moderately decreased fetal motor activity and constant flexion of the fingers were observed at both examinations. In addition, there was mild bowing and shortening of the femora. At birth, the child presented with the characteristic pattern of SJS similar to her older brother. Prenatal ultrasonic diagnosis of Schwartz–Jampel syndrome is possible, at least for the form with neonatal onset of myotonia and contractures.  相似文献   
216.
217.
218.
The recently enacted federal law, the ‘Prenatally and Postnatally Diagnosed Conditions Awareness Act’ (United States Public Law 110–374) seeks to improve opportunities for parents and pregnant women to anticipate and understand the likely life course of children born with Down syndrome and other (unspecified) conditions. The law is in part a response to the continued growth of prenatal screening and testing. For example, the American College of Obstetricians and Gynecologists' Practice Bulletin 77 recommends that ‘Screening and invasive diagnostic testing for aneuploidies be available to all women who present for prenatal care before 20 weeks of gestation regardless of maternal age.’ Emerging technologies anticipate an era in which the scope of prenatal screening and testing will be much larger than it is today. Inevitably, more women will find themselves facing the hard question of whether to continue or end a pregnancy in which a fetus has been found to have a significant abnormality. While the new federal law is not likely to have a major impact on obstetric practice, it may be a harbinger of renewed wide-scale public debate concerning the ethics of prenatal screening. Copyright © 2009 John Wiley & Sons, Ltd.  相似文献   
219.
220.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号